
Choisissez votre étiquette
affichée directement sur le flaconEzetimib
Medication
- Expédié depuis l'Allemagne
Commande
- DHL avec suivi
- Emballage discret
En un coup d'œil
Ezetimib en chiffres
Les chiffres clés de notre lexique. Faites glisser le point le long de la courbe pour voir ce qui reste après une dose, par calcul.
Article complet du lexiqueHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~22 hours
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
about22hours
- Class
- Cholesterol absorption inhibitorNPC1L1 blocker
- Use
- Oral10mg once daily
- Sizes
- 10 mg1 size in the shop
What studies show
All 7 sources in the lexiconEzetimibe added to statin therapy after acute coronary syndromes (IMPROVE-IT) (opens in a new tab)
Cannon et al., NEJM, 2015- Altmann et al., Science, 2004
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1) (opens in a new tab)
Garcia-Calvo et al., PNAS, 2005
Avis
Ce que disent les clients
Uniquement des commandes réelles qui contenaient Ezetimib.
Tous les avisIl n'existe pas encore d'analyse de laboratoire pour Ezetimib. Votez pourFaites-le tester vous-même, nous payons la moitiéToutes les analyses de laboratoire
Connaissances
Tout sur Ezetimib
Informations détaillées bientôt disponibles.
Is ezetimibe approved?
Yes. ChEMBL lists ezetimibe with phase 4 as the highest phase and first approval in 2002, as a drug for raised cholesterol. ClinicalTrials.gov lists 491 trials with ezetimibe, as of 26 October 2026.
How does ezetimibe work?
It inhibits NPC1L1, a transporter at the brush border of small intestine cells that takes up cholesterol. Mice without NPC1L1 absorbed much less cholesterol and ezetimibe no longer worked in them. A year later a binding study showed that ezetimibe binds directly to NPC1L1.
How much does ezetimibe lower LDL?
Given alone, by 18.6 percent more than placebo on average, according to the meta-analysis of eight trials over 12 weeks. Total cholesterol fell by 13.5 percent, triglycerides by 8.1 percent and HDL rose by 3.0 percent.
What did IMPROVE-IT show?
18,144 people after an acute coronary syndrome received a statin plus ezetimibe or a statin plus placebo. LDL during the trial was 1.4 instead of 1.8 mmol/l. At 7 years 32.7 instead of 34.7 percent had a cardiovascular event. The difference is small, but it was the first large proof of added benefit from a non-statin.
How long does ezetimibe stay in the body?
The half-life is about 22 hours. Ezetimibe is converted in the gut and liver into an active glucuronide that returns to the gut via the bile. About 78 percent is excreted in the faeces.
Which side effects and interactions are known?
In SHARP and IMPROVE-IT muscle, liver and gallbladder events and cancer were about as common as in the comparison group. Bile acid sequestrants such as colestyramine clearly reduce ezetimibe uptake, ciclosporin raises its level. Fibrates raise it as well, according to the review probably of minor clinical relevance.
Produits associés
Produits similaires
Telmisartan
Médicaments · Cardiovasculaire Cardiovasculaire
2 tailles
Testé en laboratoire
Ivermectin
Médicaments · Estomac et foie Estomac et foie
1 taille
Fenbendazol
Médicaments · Estomac et foie Estomac et foie
1 taille
Prednisone
Médicaments · Estomac et foie Estomac et foie
1 taille
Ezetimib